SC
GILD icon

Syon Capital’s Gilead Sciences GILD Stock Holding History

Syon Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.59M Sell
20,463
-282
-1% -$37.2K 0.11% 129
2026
Q1 		$2.89M Sell
20,745
-532
-3% -$74.5K 0.15% 99
2025
Q4 		$2.61M Buy
21,277
+1,008
+5% +$122K 0.13% 120
2025
Q3 		$2.25M Buy
20,269
+729
+4% +$82.9K 0.12% 118
2025
Q2 		$2.17M Buy
19,540
+903
+5% +$96.1K 0.14% 102
2025
Q1 		$2.09M Buy
18,637
+558
+3% +$57.6K 0.17% 91
2024
Q4 		$1.67M Buy
18,079
+3,678
+26% +$331K 0.15% 101
2024
Q3 		$1.21M Sell
14,401
-50
-0.3% -$3.81K 0.11% 143
2024
Q2 		$991K Buy
14,451
+606
+4% +$40.4K 0.09% 157
2024
Q1 		$1.01M Buy
13,845
+870
+7% +$66.9K 0.1% 153
2023
Q4 		$1.05M Buy
12,975
+529
+4% +$41.2K 0.11% 134
2023
Q3 		$933K Buy
+12,446
New +$957K 0.12% 114

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Syon Capital's GILD Position: Q2 2026 in Review

Syon Capital reduced its Gilead Sciences (GILD) stake by 1.4% in Q2 2026, selling an estimated $37.2K and leaving 20,463 shares worth $2.59M. The position accounts for 0.11% of the portfolio, ranked #129.

Syon Capital first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $2.89M in Q1 2026. 2,285 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Syon Capital held 20,463 shares of Gilead Sciences worth $2.59M as of Q2 2026.
  • Syon Capital sold 282 Gilead Sciences shares in Q2 2026, an estimated $37.2K.
  • Gilead Sciences made up 0.11% of Syon Capital's portfolio in Q2 2026, its #129 holding.
  • Syon Capital first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
  • Syon Capital's Gilead Sciences position peaked at $2.89M in Q1 2026.
  • 2,285 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Syon Capital's 13F filing for Q2 2026, filed 14 Aug 2026.